Centerpoint Advisors’s Dorman Products DORM Stock Holding History

Centerpoint Advisors’s Portfolio DORM Stock Details DORM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-21	Closed	-$1K	–	271
2018 Q2	$1K	Buy	+21	New	+$1.42K	﹤0.01%	346

Other funds holding DORM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Centerpoint Advisors's DORM Position: Q3 2018 in Review

Centerpoint Advisors sold out of Dorman Products (DORM) in Q3 2018, closing a stake of 21 shares — an estimated $1K sold.

Centerpoint Advisors first reported a position in DORM in Q2 2018 and held it in 1 quarter. The position peaked at $1K in Q2 2018. 230 funds tracked by Wall St. Rank hold DORM as of Q3 2018.

Centerpoint Advisors reported no remaining Dorman Products position as of Q3 2018 after selling out during the quarter.
Centerpoint Advisors sold 21 Dorman Products shares in Q3 2018, an estimated $1K.
Centerpoint Advisors first reported a position in Dorman Products in Q2 2018 and held it in 1 quarter.
Centerpoint Advisors's Dorman Products position peaked at $1K in Q2 2018.
230 funds tracked by Wall St. Rank held Dorman Products as of Q3 2018.

Based on Centerpoint Advisors's 13F filing for Q3 2018, filed 8 Nov 2018.